Working memory and depressive symptoms in patients with schizophrenia and substance use disorders

Cognitive Neuropsychiatry

Volumn 13, Issue 4, 2008, Pages 357-366

  Potvin, Stephane ^a,b   Pampoulova, Tania ^a   Lipp, Olivier ^a   Ait Bentaleb, Lahcen ^a   Lalonde, Pierre ^a   Stip, Emmanuel ^a,c  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

CANTAB; Depressive symptoms; Schizophrenia; Substance abuse; Working memory

Indexed keywords

ADULT; ARTICLE; CALGARY DEPRESSION SCALE FOR SCHIZOPHRENIA; CAMBRIDGE NEUROPSYCHOLOGICAL TEST AUTOMATED BATTERY; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RATING SCALE; SCHIZOPHRENIA; SUBSTANCE ABUSE; WORKING MEMORY;

ADULT; ALCOHOLISM; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORIENTATION; PATTERN RECOGNITION, VISUAL; PROBLEM SOLVING; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 47249096586     PISSN: 13546805     EISSN: 14640619     Source Type: Journal    
DOI: 10.1080/13546800802264330     Document Type: Article

References (31)

1. Addington, D., Addington, J., Maticka-Tyndale, E., & Joyce, J. (1992). Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research, 6, 201-208.
2. Bowie, C. R., Serper, M. R., Riggio, S., & Harvey, P. D. (2005). Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients. Schizophrenia Bulletin, 31, 175-182.
3. Cleghorn, J. M., Kaplan, R. D., Szechtman, B., Szechtman, H., Brown, G. M., & Franco, S. (1991). Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function. Journal of Clinical Psychiatry, 52, 26-30.
4. Drake, R. E., Osher, F. C., Noordsy, D. L., Hurlbut, S. C., Teague, G. B., & Beaudett, M. S. (1990). Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin, 16, 57-67.
5. Fray, P. J., Robbins, T. W., & Sahakian, B. J. (1996). Neuorpsychiatric applications of CANTAB. International Journal of Geriatric Psychiatry, 11, 329-336.
6. Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., et al. (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMHMATRICS conference to select cognitive domains and test criteria. Biological Psychiatry, 56, 301-307.
7. Herman, M. (2004). Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients. International Journal of Mental Health Nursing, 13, 282-291.
8. Jovanovski, D., Erb, S., & Zakzanis, K. K. (2005). Neurocognitive deficits in cocaine users: A quantitative review of the evidence. Journal of Clinical and Experimental Neuropsychology, 27, 189-204.
9. Joyal, C. C., Halle, P., Lapierre, D., & Hodgins, S. (2003). Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophrenia Research, 63, 297-299.
10. Kanayama, G., Rogowska, J., Pope, H. G., Gruber, S. A., & Yurgelun-Todd, D. A. (2004). Spatial working memory in heavy cannabis users: A functional magnetic resonance imaging study. Psychopharmacology, 176, 239-247.
11. Kavanagh, D. J., McGrath, J., Saunders, J. B., Dore, G., & Clark, D. (2002). Substance misuse in patients with schizophrenia: Epidemiology and management. Drugs, 62, 743-755.
12. Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
13. Keefe, R. S., Bilder, R. M., Harvey, P. D., Davis, S. M., Palmer, B. W., Gold, J. M., et al. (2006). Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology, 31, 2033-2046.
14. Liotti, M., & Mayberg, H. S. (2001). The role of functional neuroimaging in the neuropsychology of depression. Journal of Clinical and Experimental Neuropsychology, 23, 121-136.
15. Moselhy, H. F., Georgiou, G., & Kahn, A. (2001). Frontal lobe changes in alcoholism: A review of the literature. Alcohol and Alcoholism, 36, 357-368.
16. Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis: a review of etiological theories. Addictive Behaviors, 23, 717-734.
17. Pencer, A., & Addington, J. (2003). Substance use and cognition in early psychosis. Journal of Psychiatry and Neuroscience, 28, 48-54.
18. Potvin, S., Briand, C., Prouteau, A., Bouchard, R. H., Nicole, L., Lalonde, P., et al. (2005). CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain and Cognition, 59, 38-42.
19. Potvin, S., Joyal, C. C., Pelletier, J., & Stip, E. (2008). Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis. Schizophrenia Research, 100(1-3), 242-251.
20. Potvin, S., Sepehry, A. A., & Stip, E. (2006a). A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychological Medicine, 36, 431-440.
21. Potvin, S., Stip, E., Lipp, O., Elie, R., Mancini-Marie, A., Demers, M. F., et al. (2006b). Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: An open-label trial. Current Medical Research and Opinion, 22, 1277-1285.
22. Serper, M. R., Bergman, A., Copersino, M. L., Chou, J. C. Y., Richarme, D., & Cancro, R. (2000). Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients. Psychiatry Research, 93, 21-32.
23. Serper, M. R., Copersino, M. L., Richarme, D., Vadhan, N., & Cancro, R. (2000). Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients. Journal of Substance Abuse, 11, 205-213.
24. Sevy, S., Kay, S. R., Opler, L. A., & van Praag, H. M. (1990). Significance of cocaine history in schizophrenia. Journal of Nervous and Mental Disease, 178, 642-648.
25. Stip, E., Chouinard, S., & Boulay, L. J. (2005). On the trail of a cognitive enhancer for the treatment of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29, 219-232.
26. Stip, E., & Mancini-Marie, A. (2004). Cognitive function and depression in symptom resolution in schizophrenia patients treated with an atypical antipsychotic. Brain and Cognition, 55, 463-465.
27. Stip, E., Sepehry, A. A., Prouteau, A., Briand, C., Nicole, L., Lalonde, P., & Lesage, A. (2005). Cognitive discernable factors between schizophrenia and schizoaffective disorder. Brain and Cognition, 59, 292-295.
28. Stirling, J., Lewis, S., Hopkins, R., & White, C. (2005). Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophrenia Research, 75, 135-137.
29. Talamo, A., Centorrino, F., Tondo, L., Dimitri, A., Hennen, J., & Baldessarini, R. J. (2006). Comorbid substance-use in schizophrenia: Relation to positive and negative symptoms. Schizophrenia Research, 86, 251-255.
30. Thoma, R. J., Hanlon, F. M., Miller, G. A., Huang, M., Weisend, M. P., Sanchez, F. P., et al. (2006). Neuropsychological and sensory gating deficits related to remote alcohol abuse history in schizophrenia. Journal of the International Neuropsychological Society, 12, 34-44.
31. Ziedonis, D., Steinberg, M. L., Smelson, D., & Wyatt, S. (2003). Co-occurring addictive and psychotic disorders. In A. W. Graham, T. K. Schultz, M. F. Mayo-Smith, R. K. Ries, & B. B. Wilford (Eds.), Principles of addiction medicine (3rd ed., pp. 1297-1319). Chevy Chase, MD: American Society of Addiction Medicine.